Product Categories
Company Name: | Shanghai Mathcon Pharmaceutical Co.,LTD. |
Tel: | 021-50875908 13838295781 |
Email: | sales@hasunny.com |
WebSite: | http://www.shmathcon.com |
Product Total: | 2999 |
CB Index: | 58 |
Nationality: | China |
- |
Product Name | MF | CAS | Details |
---|
Acrizanib | C20H18F3N7O2 | 1229453-99-9 | Details |
Lazertinib | C30H34N8O3 | 1903008-80-9 | Details |
Momelotinib (CYT387) | C23H22N6O2 | 1056634-68-4 | Details |
Lenvatinib | C21H19ClN4O4 | 417716-92-8 | Details |
Rezivertinib | C27H30N6O3 | 1835667-12-3 | Details |
3-((1R,3S,5S)-3-((7-((5-Methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amino)-8-azabicyclo[3.2.1]octan-8-yl)propanenitrile | C22H26N8 | 2051918-33-1 | Details |
Tivozanib | C22H19ClN4O5 | 475108-18-0 | Details |
Momelotinib sulfate | C23H26N6O10S2 | 1056636-06-6 | Details |
Tolebrutinib | C26H25N5O3 | 1971920-73-6 | Details |
Vecabrutinib | C22H24ClF4N7O2 | 1510829-06-7 | Details |
Tomivosertib | C17H20N6O2 | 1849590-01-7 | Details |
EAI045 | C19H14FN3O3S | 1942114-09-1 | Details |
Tyrosine kinase-IN-1 | C26H28FN5O | 705946-27-6 | Details |
AEE788 | C27H32N6 | 497839-62-0 | Details |
Tesirine (SG3249, MP-PEG8-VA-PABC-PBD DIMER) | C75H101N9O23 | 1595275-62-9 | Details |
Varlitinib | C22H19ClN6O2S | 845272-21-1 | Details |
ARRY-380 (analog ) | C29H27N7O4S | 937265-83-3 | Details |
Ningetinib Tosylate | C38H37FN4O8S | 1394820-77-9 | Details |
MTX-211 | C20H14Cl2FN5O2S | 1952236-05-3 | Details |
Ningetinib | C31H29FN4O5 | 1394820-69-9 | Details |
Golidocitinib | C25H31N9O2 | 2091134-68-6 | Details |
Epertinib (hydrochloride) | C30H28Cl2FN5O3 | 2071195-74-7 | Details |
Vorolanib | C23H26FN5O3 | 1013920-15-4 | Details |
Poseltinib | C26H26N6O3 | 1353552-97-2 | Details |
AX-024 | C21H22FNO2 | 1370544-73-2 | Details |
AX-024 hydrochloride | C21H23ClFNO2 | 1704801-24-0 | Details |
Abrocitinib | C14H21N5O2S | 1622902-68-4 | Details |
AG-494 | C16H12N2O3 | 133550-35-3 | Details |
PF-6274484 | C18H14ClFN4O2 | 1035638-91-5 | Details |
BMS-935177 | C31H26N4O3 | 1231889-53-4 | Details |
FLLL32 | C28H32O6 | 1226895-15-3 | Details |
OSI-930 | C22H16F3N3O2S | 728033-96-3 | Details |
Hispidol | C15H10O4 | 5786-54-9 | Details |
Cediranib | C25H27FN4O3 | 288383-20-0 | Details |
Motesanib | C22H23N5O | 453562-69-1 | Details |
Motesanib (Diphosphate) | C22H29N5O9P2 | 857876-30-3 | Details |
SU5408 | C18H18N2O3 | 15966-93-5 | Details |
TG 100801 | C33H30ClN5O3 | 867331-82-6 | Details |
JAK3-IN-6 | C19H18N4O3 | 1443235-95-7 | Details |
FM-381 | C24H24N6O2 | 2226521-65-7 | Details |
(±)-Zanubrutinib | C27H29N5O3 | 1633350-06-7 | Details |
(2R,5S)-Ritlecitinib | C15H19N5O | 1792180-79-0 | Details |
Dihydrodiol-Ibrutinib | C25H26N6O4 | 1654820-87-7 | Details |
Simotinib | C25H26ClFN4O4 | 944258-89-3 | Details |
Zanubrutinib | C27H29N5O3 | 1691249-45-2 | Details |
CL-387785 | C18H13BrN4O | 194423-06-8 | Details |
Falnidamol | C18H19ClFN7 | 196612-93-8 | Details |
BMS-690514 | C19H24N6O2 | 859853-30-8 | Details |
1-((2S,5R)-5-((7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one | C15H19N5O | 1792180-81-4 | Details |
Brivanib (alaninate) | C22H24FN5O4 | 649735-63-7 | Details |
Brivanib | C19 H19 F N4 O3 | 649735-46-6 | Details |
Foretinib | C34H34F2N4O6 | 849217-64-7 | Details |
Fedratinib | C27H36N6O3S | 936091-26-8 | Details |
SU14813 | C23H27FN4O4 | 627908-92-3 | Details |
Telatinib (mesylate) | C21H20ClN5O6S | 332013-26-0 | Details |
Telatinib | C20H16ClN5O3 | 332012-40-5 | Details |
BMS-794833 | C23H15ClF2N4O3 | 1174046-72-0 | Details |
K00546 | C15H13F2N7O2S2 | 443798-47-8 | Details |
Ki20227 | C24H24N4O5S | 623142-96-1 | Details |
TG101209 | C26H35N7O2S | 936091-14-4 | Details |
AZ960 | C18H16F2N6 | 905586-69-8 | Details |
Theliatinib | C25H26N6O2 | 1353644-70-8 | Details |
Fedratinib (hydrochloride hydrate) | C27H40Cl2N6O4S | 1374744-69-0 | Details |
Belzutifan (PT2977, MK-6482) | C17H12F3NO4S | 1672668-24-4 | Details |
ENMD-2076 | C21H25N7 | 934353-76-1 | Details |
ENMD-2076 L-(+)-Tartaric acid | C21H25N7.x(C4H6O6) | 1291074-87-7 | Details |
Ibrutinib (Racemate) | C25H24N6O2 | 936563-87-0 | Details |
MGCD-265 analog | C26H20FN5O2S2 | 875337-44-3 | Details |
(Z)-Guggulsterone | C21H28O2 | 39025-23-5 | Details |
Ibrutinib;PCI-32765 | C25H24N6O2 | 936563-96-1 | Details |
Resatorvid | C15H17ClFNO4S | 243984-11-4 | Details |
WHI-P97 | C16H13Br2N3O3 | 211555-05-4 | Details |
R-7050 | C16H8ClF3N4S | 303997-35-5 | Details |
Tyk2-IN-5 | C21H19FN8O2 | 1797432-62-2 | Details |
Branebrutinib | C20H23FN4O2 | 1912445-55-6 | Details |
Rilzabrutinib | C36H40FN9O3 | 1575596-29-0 | Details |
ARQ 531 | C25 H23 Cl N4 O4 | 2095393-15-8 | Details |
TAS0728 | C26H32N8O3 | 2088323-16-2 | Details |
TNF-α-IN-1 | C16H14ClN3O5 | 444287-49-4 | Details |
Ripretinib | C24H21BrFN5O2 | 1442472-39-0 | Details |
TAS6417 | C23H20N6O | 1661854-97-2 | Details |
JAK-IN-5 (hydrochloride) | C27H32ClFN6O | 2751323-21-2 | Details |
Thalidomide-O-COOH | C15H12N2O7 | 1061605-21-7 | Details |
(S,R,S)-AHPC hydrochloride | C22H31ClN4O3S | 1448189-80-7 | Details |
Lenalidomide-Br | C13H11BrN2O3 | 2093387-36-9 | Details |
Propargyl-PEG4-amine | C11H21NO4 | 1013921-36-2 | Details |
Propargyl-PEG12-OH | C27H52O13 | 1036204-61-1 | Details |
Boc-11-aminoundecanoic acid | C16H31NO4 | 10436-25-6 | Details |
PF-05231023 | C26H32N4O8 | 1037589-69-7 | Details |
Bestatin-amido-Me | C17H27N3O3 | 339186-54-8 | Details |
(+)-JQ1 | C23H25ClN4O2S | 1268524-70-4 | Details |
Quizartinib | C29H32N6O4S | 950769-58-1 | Details |
Auristatin E | C40H69N5O7 | 160800-57-7 | Details |
Auristatin F | C40H67N5O8 | 163768-50-1 | Details |
DC0-NH2 | C31H24ClN5O3 | 615538-51-7 | Details |
Dxd (Exatecan derivative) | C26H24FN3O6 | 1599440-33-1 | Details |
(Ac)Phe-Lys(Alloc)-PABC-PNP | C35H39N5O10 | 2070009-39-9 | Details |
SMCC | C16H18N2O6 | 64987-85-5 | Details |
Iberdomide | C25H27N3O5 | 1323403-33-3 | Details |
EGFR/ErbB-2/ErbB-4 inhibitor-2 | C23H21N3O3 | 179248-61-4 | Details |
Product Total: Product Page: | ||||
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 |